Molecular determinants of biased Agonism at the dopamine D2 receptor

Journal of Medicinal Chemistry

Volumn 58, Issue 6, 2015, Pages 2703-2717

  Weichert, Dietmar ^a   Banerjee, Ashutosh ^a   Hiller, Christine ^a   Kling, Ralf C ^a   Hubner, Harald ^a   Gmeiner, Peter ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; DOPAMINE; LIGAND; RETINA S ANTIGEN;

ARTICLE; DRUG SYNTHESIS; ENANTIOMER; MOLECULAR DYNAMICS; PHARMACOPHORE; PROTEIN STRUCTURE; STEREOCHEMISTRY; AGONISTS; ANALOGS AND DERIVATIVES; CHEMICAL STRUCTURE; DRUG EFFECTS; HEK293 CELL LINE; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

ARRESTINS; DOPAMINE; GTP-BINDING PROTEINS; HEK293 CELLS; HUMANS; LIGANDS; MODELS, MOLECULAR; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION;

EID: 84925949750     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm501889t     Document Type: Article

References (74)

1. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci Nature 2014, 511, 421-427
2. Davis, K. L.; Kahn, R. S.; Ko, G.; Davidson, M. Dopamine in schizophrenia: a review and reconceptualization Am. J. Psychiatry 1991, 148, 1474-1486
3. Beaulieu, J.-M.; Gainetdinov, R. R. The physiology, signaling, and pharmacology of dopamine receptors Pharmacol. Rev. 2011, 63, 182-217
4. Ye, N.; Neumeyer, J. L.; Baldessarini, R. J.; Zhen, X.; Zhang, A. Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders Chem. Rev. 2013, 113, PR123-PR178
5. Lindgren, N.; Usiello, A.; Goiny, M.; Haycock, J.; Erbs, E.; Greengard, P.; Hokfelt, T.; Borrelli, E.; Fisone, G. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 4305-4309
6. Gazi, L.; Nickolls, S. A.; Strange, P. G. Functional coupling of the human dopamine D2 receptor with Gi1, Gi2, Gi3 and Go G proteins: evidence for agonist regulation of G protein selectivity Br. J. Pharmacol. 2003, 138, 775-786
7. Urban, J. D.; Clarke, W. P.; von Zastrow, M.; Nichols, D. E.; Kobilka, B.; Weinstein, H.; Javitch, J. A.; Roth, B. L.; Christopoulos, A.; Sexton, P. M.; Miller, K. J.; Spedding, M.; Mailman, R. B. Functional selectivity and classical concepts of quantitative pharmacology J. Pharmacol. Exp. Ther. 2007, 320, 1-13
8. Neve, K. A. Functional Selectivity of G Protein-Coupled Receptor Ligands-New Opportunities for Drug Discovery, 1st ed.; Humana Press: Totowa, NJ, 2009; pp 25-40.
9. Rajagopal, K.; Lefkowitz, R. J.; Rockman, H. A. When 7 transmembrane receptors are not G protein-coupled receptors J. Clin. Invest. 2005, 115, 2971-2974
10. Masri, B.; Salahpour, A.; Didriksen, M.; Ghisi, V.; Beaulieu, J.-M.; Gainetdinov, R. R.; Caron, M. G. Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 13656-13661
11. Allen, J. A.; Yost, J. M.; Setola, V.; Chen, X.; Sassano, M. F.; Chen, M.; Peterson, S.; Yadav, P. N.; Huang, X.-p.; Feng, B.; Jensen, N. H.; Che, X.; Bai, X.; Frye, S. V.; Wetsel, W. C.; Caron, M. G.; Javitch, J. A.; Roth, B. L.; Jin, J. Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 18488-18493
12. Chen, X.; Sassano, M. F.; Zheng, L.; Setola, V.; Chen, M.; Bai, X.; Frye, S. V.; Wetsel, W. C.; Roth, B. L.; Jin, J. Structure-functional selectivity relationship studies of beta-arrestin-biased dopamine D(2) receptor agonists J. Med. Chem. 2012, 55, 7141-7153
13. Shonberg, J.; Herenbrink, C. K.; Lopez, L.; Christopoulos, A.; Scammells, P. J.; Capuano, B.; Lane, J. R. A Structure-activity analysis of biased agonism at the dopamine D2 receptor J. Med. Chem. 2013, 56, 9199-9221
14. Szabo, M.; Klein Herenbrink, C.; Christopoulos, A.; Lane, J. R.; Capuano, B. Structure-activity relationships of privileged structures lead to the discovery of novel biased ligands at the dopamine D2 receptor J. Med. Chem. 2014, 57, 4924-4939
15. Dorfler, M.; Tschammer, N.; Hamperl, K.; Hubner, H.; Gmeiner, P. Novel D3 selective dopaminergics incorporating enyne units as nonaromatic catechol bioisosteres: synthesis, bioactivity, and mutagenesis studies J. Med. Chem. 2008, 51, 6829-6838
16. Hiller, C.; Kling, R. C.; Heinemann, F. W.; Meyer, K.; Hubner, H.; Gmeiner, P. Functionally selective dopamine D2/D3 receptor agonists comprising an enyne moiety J. Med. Chem. 2013, 56, 5130-5141
17. Tschammer, N.; Elsner, J.; Goetz, A.; Ehrlich, K.; Schuster, S.; Ruberg, M.; Kuhhorn, J.; Thompson, D.; Whistler, J.; Hubner, H.; Gmeiner, P. Highly potent 5-aminotetrahydropyrazolopyridines: enantioselective dopamine D3 receptor binding, functional selectivity, and analysis of receptor-ligand interactions J. Med. Chem. 2011, 54, 2477-2491
18. Tschammer, N.; Bollinger, S.; Kenakin, T.; Gmeiner, P. Histidine 6.55 is a major determinant of ligand-biased signaling in dopamine D2L receptor Mol. Pharmacol. 2011, 79, 575-585
19. Moller, D.; Kling, R. C.; Skultety, M.; Leuner, K.; Hubner, H.; Gmeiner, P. Functionally selective dopamine D2, D3 receptor partial agonists J. Med. Chem. 2014, 57, 4861-4875
20. Wacker, D.; Wang, C.; Katritch, V.; Han, G. W.; Huang, X. P.; Vardy, E.; McCorvy, J. D.; Jiang, Y.; Chu, M.; Siu, F. Y.; Liu, W.; Xu, H. E.; Cherezov, V.; Roth, B. L.; Stevens, R. C. Structural features for functional selectivity at serotonin receptors Science 2013, 340, 615-619
21. Wang, C.; Jiang, Y.; Ma, J.; Wu, H.; Wacker, D.; Katritch, V.; Han, G. W.; Liu, W.; Huang, X.-P.; Vardy, E.; McCorvy, J. D.; Gao, X.; Zhou, X. E.; Melcher, K.; Zhang, C.; Bai, F.; Yang, H.; Yang, L.; Jiang, H.; Roth, B. L.; Cherezov, V.; Stevens, R. C.; Xu, H. E. Structural basis for molecular recognition at serotonin receptors Science 2013, 340, 610-614
22. Kaiser, C.; Dandridge, P. A.; Garvey, E.; Flaim, K. E.; Zeid, R. L.; Hieble, J. P. Dopamine receptor agonist activity of some 5-(2-aminoethyl)carbostyril derivatives J. Med. Chem. 1985, 28, 1803-1810
23. Cannon, J. G. Structure-activity relationships of dopamine agonists Annu. Rev. Pharmacol. Toxicol. 1983, 23, 103-129
24. Elsner, J.; Boeckler, F.; Heinemann, F. W.; Hubner, H.; Gmeiner, P. Pharmacophore-guided drug discovery investigations leading to bioactive 5-aminotetrahydropyrazolopyridines. Implications for the binding mode of heterocyclic dopamine D3 receptor agonists J. Med. Chem. 2005, 48, 5771-5779
25. Wiens, B. L.; Nelson, C. S.; Neve, K. A. Contribution of serine residues to constitutive and agonist-induced signaling via the D2S dopamine receptor: evidence for multiple, agonist-specific active conformations Mol. Pharmacol. 1998, 54, 435-444
26. Coley, C.; Woodward, R.; Johansson, A. M.; Strange, P. G.; Naylor, L. H. Effect of multiple serine/alanine mutations in the transmembrane spanning region V of the D2 dopamine receptor on ligand binding J. Neurochem. 2000, 74, 358-366
27. Shimizu, T.; Murakoshi, K.; Yasui, K.; Sodeoka, M. A new route for the preparation of succinates Synthesis 2008, 20, 3209-3218
28. Koide, M.; Kume, K. Preparation of [(trifluoromethyl)phenyl]acetic acids from (trifluoromethyl)benzenes and vinyl compounds. JP2001302582A, 2001.
29. Shenoy, S. K.; Drake, M. T.; Nelson, C. D.; Houtz, D. A.; Xiao, K.; Madabushi, S.; Reiter, E.; Premont, R. T.; Lichtarge, O.; Lefkowitz, R. J. β-Arrestin-dependent G Protein-independent ERK1/2 activation by the β2 adrenergic receptor J. Biol. Chem. 2006, 281, 1261-1273
30. Shonberg, J.; Lopez, L.; Scammells, P. J.; Christopoulos, A.; Capuano, B.; Lane, J. R. Biased agonism at G protein-coupled receptors: the promise and the challenges-a medicinal chemistry perspective Med. Res. Rev. 2014, 34, 1286-1330
31. Senogles, S. E. The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gi alpha proteins J. Biol. Chem. 1994, 269, 23120-23127
32. Wise, A.; Watson-Koken, M. A.; Rees, S.; Lee, M.; Milligan, G. Interactions of the alpha2A-adrenoceptor with multiple Gi-family G-proteins: Studies with pertussis toxin-resistant G-protein mutants Biochem. J. 1997, 321, 721-728
33. Pauwels, P. J.; Tardif, S.; Wurch, T.; Colpaert, F. C. Facilitation of constitutive 2A-adrenoceptor activity by both single amino acid mutation (Thr373Lys) and Go protein coexpression: evidence for inverse agonism J. Pharmacol. Exp. Ther. 2000, 292, 654-663
34. Black, J. W.; Leff, P. Operational models of pharmacological agonism Proc. R. Soc. B 1983, 220, 141-162
35. Kenakin, T.; Watson, C.; Muniz-Medina, V.; Christopoulos, A.; Novick, S. A simple method for quantifying functional selectivity and agonist bias ACS Chem. Neurosci. 2011, 3, 193-203
36. Kenakin, T.; Christopoulos, A. Measurements of ligand bias and functional affinity Nature Rev. Drug Discovery 2013, 12, 483-483
37. Kenakin, T.; Christopoulos, A. Signalling bias in new drug discovery: detection, quantification and therapeutic impact Nature Rev. Drug Discovery 2013, 12, 205-216
38. Wikstroem, H.; Andersson, B.; Sanchez, D.; Lindberg, P.; Arvidsson, L. E.; Johansson, A. M.; Nilsson, J. L. G.; Svensson, K.; Hjorth, S.; Carlsson, A. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[ f ]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists J. Med. Chem. 1985, 28, 215-225
39. Liu, J. J.; Horst, R.; Katritch, V.; Stevens, R. C.; Wuthrich, K. Biased signaling pathways in beta2-adrenergic receptor characterized by 19F-NMR Science 2012, 335, 1106-1110
40. Warne, T.; Edwards, P. C.; Leslie, A. G.; Tate, C. G. Crystal structures of a stabilized beta1-adrenoceptor bound to the biased agonists bucindolol and carvedilol Structure 2012, 20, 841-849
41. Rahmeh, R.; Damian, M.; Cottet, M.; Orcel, H.; Mendre, C.; Durroux, T.; Sharma, K. S.; Durand, G.; Pucci, B.; Trinquet, E.; Zwier, J. M.; Deupi, X.; Bron, P.; Baneres, J.-L.; Mouillac, B.; Granier, S. Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 6733-6738
42. Correll, C. C.; McKittrick, B. A. Biased ligand modulation of seven transmembrane receptors (7TMRs): functional implications for drug discovery J. Med. Chem. 2014, 16, 6887-6896
43. Violin, J. D.; DeWire, S. M.; Yamashita, D.; Rominger, D. H.; Nguyen, L.; Schiller, K.; Whalen, E. J.; Gowen, M.; Lark, M. W. Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance J. Pharmacol. Exp. Ther. 2010, 335, 572-579
44. Groer, C. E.; Tidgewell, K.; Moyer, R. A.; Harding, W. W.; Rothman, R. B.; Prisinzano, T. E.; Bohn, L. M. An opioid agonist that does not induce μ-opioid receptor-arrestin interactions or receptor internalization Mol. Pharmacol. 2007, 71, 549-557
45. Bromberg, K. D.; Iyengar, R.; He, J. C. Regulation of neurite outgrowth by Gi/o signaling pathways Front. Biosci. 2008, 13, 4544-4557
46. Nakata, H.; Kozasa, T. Functional characterization of Go signaling through G protein-regulated inducer of neurite outgrowth 1 Mol. Pharmacol. 2005, 67, 695-702
47. Strittmatter, S. M.; Fishman, M. C.; Zhu, X. P. Activated mutants of the alpha subunit of G(o) promote an increased number of neurites per cell J. Neurosci. 1994, 14, 2327-2338
48. Hwangpo, T. A.; Jordan, J. D.; Premsrirut, P. K.; Jayamaran, G.; Licht, J. D.; Iyengar, R.; Neves, S. R. G protein-regulated inducer of neurite outgrowth (GRIN) modulates sprouty protein repression of mitogen-activated protein kinase (MAPK) activation by growth factor stimulation J. Biol. Chem. 2012, 287, 13674-13685
49. Allen, J. A.; Yost, J. M.; Setola, V.; Chen, X.; Sassano, M. F.; Chen, M.; Peterson, S.; Yadav, P. N.; Huang, X. P.; Feng, B.; Jensen, N. H.; Che, X.; Bai, X.; Frye, S. V.; Wetsel, W. C.; Caron, M. G.; Javitch, J. A.; Roth, B. L.; Jin, J. Discovery of beta-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 18488-18493
50. Kuhhorn, J.; Gotz, A.; Hubner, H.; Thompson, D.; Whistler, J.; Gmeiner, P. Development of a bivalent dopamine D2 receptor agonist J. Med. Chem. 2011, 54, 7911-7919
51. Davidov, E.; Spiegelstein-Klarfeld, H.; Gizri-Yaron, O.; Naim, E.; Lichtenstein, N. New Derivatives of l -glutamine Isr. J. Chem. 1969, 7, 487-489
52. Hansen, S. G.; Jensen, H. H. Microwave irradiation as an effective means of synthesizing unsubstituted N-linked 1,2,3-triazoles from vinyl acetate and azides Synlett 2009, 20, 3275-3278
53. Rosenbaum, D. M.; Zhang, C.; Lyons, J. A.; Holl, R.; Aragao, D.; Arlow, D. H.; Rasmussen, S. G.; Choi, H. J.; Devree, B. T.; Sunahara, R. K.; Chae, P. S.; Gellman, S. H.; Dror, R. O.; Shaw, D. E.; Weis, W. I.; Caffrey, M.; Gmeiner, P.; Kobilka, B. K. Structure and function of an irreversible agonist-beta(2) adrenoceptor complex Nature 2011, 469, 236-240
54. Hubner, H.; Haubmann, C.; Utz, W.; Gmeiner, P. Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D-3 subtype J. Med. Chem. 2000, 43, 756-762
55. Tschammer, N.; Elsner, J.; Goetz, A.; Ehrlich, K.; Schuster, S.; Ruberg, M.; Kuhhorn, J.; Thompson, D.; Whistler, J.; Hubner, H.; Gmeiner, P. Highly potent 5-aminotetrahydropyrazolopyridines: enantioselective dopamine D3 receptor binding, functional selectivity, and analysis of receptor-ligand interactions J. Med. Chem. 2011, 54, 2477-2491
56. Hayes, G.; Biden, T. J.; Selbie, L. A.; Shine, J. Structural subtypes of the dopamine D2 receptor are functionally distinct: Expression of the cloned D2A and D2B subtypes in a heterologous cell line Mol. Endocrinol. 1992, 6, 920-926
57. Sokoloff, P.; Giros, B.; Martres, M. P.; Bouthenet, M. L.; Schwartz, J. C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics Nature 1990, 347, 146-151
58. Asghari, V.; Sanyal, S.; Buchwaldt, S.; Paterson, A.; Jovanovic, V.; Van Tol, H. H. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants J. Neurochem. 1995, 65, 1157-1165
59. Jordan, M.; Schallhorn, A.; Wurm, F. M. Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation Nucleic Acids Res. 1996, 24, 596-601
60. Huebner, H.; Haubmann, C.; Utz, W.; Schmidt, S.; Schmidt, R.; Gmeiner, P. Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D3 subtype J. Med. Chem. 2000, 43, 756-762
61. Bettinetti, L.; Schlotter, K.; Hubner, H.; Gmeiner, P. Interactive SAR studies: rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists J. Med. Chem. 2002, 45, 4594-4597
62. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with the folin phenol reagent J. Biol. Chem. 1951, 193, 265-275
63. Cheng, Y.-C.; Prusoff, W. H. Relation between the inhibition constant (K1) and the concentration of inhibitor which causes fifty per cent inhibition (I50) of an enzymic reaction Biochem. Pharmacol. 1973, 22, 3099-3108
64. Shonberg, J.; Herenbrink, C. K.; Lopez, L.; Christopoulos, A.; Scammells, P. J.; Capuano, B.; Lane, J. R. A structure-activity analysis of biased agonism at the dopamine D2 receptor J. Med. Chem. 2013, 56, 9199-221
65. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J. A.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian 09, revision B.01; Gaussian: Wallingford CT, 2009.
66. Trott, O.; Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading J. Comput. Chem. 2010, 31, 455-461
67. Goetz, A.; Lanig, H.; Gmeiner, P.; Clark, T. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor J. Mol. Biol. 2011, 414, 611-623
68. Wolf, M. G.; Hoefling, M.; Aponte-Santamaria, C.; Grubmuller, H.; Groenhof, G. G-membed: efficient insertion of a membrane protein into an equilibrated lipid bilayer with minimal perturbation J. Comput. Chem. 2010, 31, 2169-2174
69. Wang, J.; Wolf, R. M.; Caldwell, J. W.; Kollman, P. A.; Case, D. A. Development and testing of a General Amber force field J. Comput. Chem. 2004, 25, 1157-1174
70. Hornak, V.; Abel, R.; Okur, A.; Strockbine, B.; Roitberg, A.; Simmerling, C. Comparison of multiple amber force fields and development of improved protein backbone parameters Proteins 2006, 65, 712-725
71. Berendsen, H. J. C.; Grigera, J. R.; Straatsma, T. P. The missing term in effective pair potentials J. Phys. Chem. 1987, 91, 6269-6271
72. Van Der Spoel, D.; Lindahl, E.; Hess, B.; Groenhof, G.; Mark, A. E.; Berendsen, H. J. GROMACS: fast, flexible, and free J. Comput. Chem. 2005, 26, 1701-1718
73. Case, D. A.; Darden, T. A.; Cheatham, T. E., III; Simmerling, C. L.; Wang, J.; Duke, R. E.; Luo, R.; Crowley, M.; Walker, R. C.; Zhang, W.; Merz, K. M.; Wang, B.; Hayik, S.; Roitberg, A.; Seabra, G.; Kolossváry, I.; Wong, K. F.; Paesani, F.; Vanicek, J.; Wu, X.; Brozell, S. R.; Steinbrecher, T.; Gohlke, H.; Yang, L.; Tan, C.; Mongan, J.; Hornak, V.; Cui, G.; Mathews, D. H.; Seetin, M. G.; Sagui, C.; Babin, V.; Kollman, P. A. AMBER 10; University of California, San Francisco: San Francisco, CA, 2008.
74. Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.; Greenblatt, D. M.; Meng, E. C.; Ferrin, T. E. UCSF Chimera-a visualization system for exploratory research and analysis J. Comput. Chem. 2004, 25, 1605-1612